Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science Trust

Journal of Oncology Pharmacy Practice

Volumn 4, Issue 1, 1998, Pages 10-14

  Baker, James P ^a   Jones, Sarah E ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Audit; Chemotherapy services; Pharmacy

Indexed keywords

EID: 0002944421     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/107815529800400101     Document Type: Article

References (6)

1. The Patient's Charter. Department of Health, London HMSO, 1996.
2. Allwood M., Stanley A., Wright P. The Cytotoxics Handbook. 3rd ed., Oxford: Radcliffe Medical Press; 1997.
3. Bonadonna G., Valagussa P., Molitemi A.,et al.Adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF), in node positive breast cancer: the results of 20 years of follow up. N Engl J Med. 1995;332:901.
4. Anon. Development of a dose banding system. The Pharm J. 1996;256:297.
5. EL[95]51-A policy framework for commissioning cancer services. London, NHS Executive. 1995.
6. Aseptic Dispensing for NHS Patients, Department of Health, London HMSO, 1995.